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Abstract 32 
 33 
Chromogranin A (CgA) is widely expressed in endocrine and neuroendocrine tissues as well as in the central 34 
nervous system. We observed CgA expression (mRNA and protein) in the gastrocnemius (GAS) muscle and 35 
found that performance of CgA-deficient Chga-KO mice in treadmill exercise was impaired. Supplementation 36 
with CgA in Chga-KO mice restored exercise ability suggesting a novel role for endogenous CgA in skeletal 37 
muscle function. Chga-KO mice display (i) lack of exercise-induced stimulation of pAKT, pTBC1D1 and 38 
phospho-p38 kinase signaling, (ii) loss of GAS muscle mass, (iii) extensive formation of tubular aggregates (TA), 39 
(iv) disorganized cristae architecture in mitochondria, (v) increased expression of the inflammatory cytokines 40 
Tnfα, Il6 and Ifnɣ, and fibrosis. The impaired maximum running speed and endurance in the treadmill exercise in 41 
Chga-KO mice correlated with decreased glucose uptake and glycolysis, defects in glucose oxidation and 42 
decreased mitochondrial cytochrome C oxidase activity. The lack of adaptation to endurance training correlated 43 
with the lack of stimulation of p38MAPK that is known to mediate the response to tissue damage. Since CgA 44 
sorts proteins to the regulated secretory pathway, we speculate that lack of CgA could cause misfolding of 45 
membrane proteins inducing aggregation of sarcoplasmic reticulum (SR) membranes and formation of tubular 46 
aggregates that is observed in Chga-KO mice. In conclusion, CgA deficiency renders the muscle energy 47 
deficient, impairs performance in treadmill exercise and prevents regeneration after exercise-induced tissue 48 
damage. 49 
  50 
Page 2 of 43
Introduction 51 
 52 
Chromogranin A (CgA), the secretory proprotein of chromaffin granules, is widely expressed in endocrine and 53 
neuroendocrine tissues as well as in the central nervous system (Winkler and Fischer-Colbrie 1992; Montero-54 
Hadjadje, et al. 2008; Bartolomucci, et al. 2011). CgA is processed to multiple biologically active peptides 55 
including pancreastatin (Tatemoto, et al. 1986; Sanchez-Margalet, et al. 2010), vasostatin I (Aardal, et al. 1993; 56 
Tota, et al. 2008), catestatin (Mahata, et al. 1997; Mahata, et al. 2003; Mahapatra, et al. 2005; Angelone, et al. 57 
2008), and serpinin (Tota, et al. 2012). The CgA protein was initially detected in the large dense-core vesicles of 58 
sympathetic nerves and in the brainstem, which is rich in adrenergic neurons (Banks, et al. 1969; De Potter, et 59 
al. 1970a; Bartlett, et al. 1976). Therefore, it was assumed that CgA is an adrenergic protein confined to the 60 
sympathetic nerve (Banks et al. 1969; De Potter, et al. 1970b; Bartlett et al. 1976) and to the adrenal medulla 61 
(Helle 1966; Smith and Winkler 1967; Smith and Kirshner 1967). Subsequently CgA was also detected in 62 
cholinergic motor neurons of the spinal cord (Somogyi, et al. 1984) and in cholinergic nerve terminals in the 63 
muscles of the diaphragm (Volknandt, et al. 1987). These latter findings suggested that CgA might influence 64 
skeletal muscle function and indeed CgA knockout mice display impaired skeletal muscle function in addition to 65 
hyperadrenergic (Mahapatra et al. 2005), hypertensive (Mahapatra et al. 2005) and insulin sensitive phenotypes 66 
(Gayen, et al. 2009). 67 
During exercise, the muscle’s increased need for energy is compensated by increasing uptake and 68 
utilization of glucose as the primary energy source (Goodyear and Kahn 1998). Both exercise and insulin 69 
increase glucose uptake in skeletal muscle through the translocation of the Glut4 glucose transporter from an 70 
intracellular compartment to the surface of the cell in response to activation of the Rab GTPase TBC1D1 71 
(Douen, et al. 1989; Hirshman, et al. 1990; Goodyear, et al. 1991a; Goodyear, et al. 1991b). Muscle contraction 72 
recruits Glut4 to the plasma membrane independently of insulin in rat skeletal muscle, suggesting alternative but 73 
convergent signaling (Goodyear, et al. 1990). Therefore, a combination of exercise and insulin can exert 74 
additive effects on glucose transport. 75 
Exercise injures skeletal muscle by damaging the attachment of myofibrils to the extrasarcolemic 76 
cytoskeleton (Friden, et al. 1991), and evoking an inflammatory response (Paulsen, et al. 2013). A number of 77 
intracellular mechanisms contribute to muscle damage including calcium overload, reactive oxygen species 78 
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(ROS) production and a decrease in cellular ATP (Armstrong, et al. 1991). This fall in ATP levels in response to 79 
exercise stress (Perrey and Rupp 2009) activates Pgc1α, AMPK and p38MAPK kinase signaling to allow cells to 80 
adapt (Gibala 2009). This post-exercise response involves mitochondrial biogenesis concomitant with the onset 81 
of muscle fiber differentiation (Duguez, et al. 2002; Gibala 2009). Regeneration of muscle fibers takes place 82 
through the activation of quiescent muscle precursor cells, the formation of proliferating progenitor satellite cells 83 
leading to fusion into differentiated myofibers (Wagers and Conboy 2005). The intermediate progenitor cells 84 
express MyoD and myogenic transcription factor Pax3, and asymmetrically divide and differentiate into 85 
myoblasts expressing Pax3, Myf-5 and desmin (Conboy and Rando 2002). The activation of satellite cells under 86 
the basal lamina of muscle fibers is accelerated by insulin-like growth factor-I and mechano-growth factor 87 
induced in exhausted muscles after training (Machida and Booth 2004; Schiaffino and Mammucari 2011). 88 
Exercise-induced muscle pain, stiffness, and cramping are caused by enzyme deficiencies such as 89 
myophosphorylase deficiency and phosphofructokinase deficiency leading to metabolic defects (Tarui, et al. 90 
1965; Layzer, et al. 1967; Cornelio and Di Donato 1985). Both deficiencies are accompanied by reduced 91 
anaerobic glycolysis resulting in reduced levels of muscle lactate production, higher serum creatine 92 
phosphokinase levels, and the presence of histological tubular aggregates (TA) in type-II muscle fibers 93 
(Bertorini, et al. 1977; Korenyi-Both, et al. 1977). TAs are ordered arrays of cylindrical sarcoplasmic reticulum 94 
(SR) tubules that are observed in many skeletal muscle myopathies (Boncompagni, et al. 2012). Experimental 95 
inhibition of glycolysis with iodoacetate produces a similar muscle phenotype (Brumback, et al. 1980) and these 96 
TAs have been found in other experimental models including extreme hypoxia in rats (Schiaffino, et al. 1977) 97 
and the deficiency of dystrophin (Craig and Allen 1980), or Caveolin-1 or -2 (Schubert, et al. 2007) in mice. The 98 
formation of TAs in injured muscle fibers may be associated with exercise-induced muscle pain (Brumback, et 99 
al. 1981).  Accumulation of calsequestrin, a sarcoplasmic reticulum (SR) Ca
2+
 binding protein, triggers TA 100 
formation through swelling of free SR cisternae and extension of the enlarged SR sacs into multiple, 101 
longitudinally oriented tubules with SERCA (sarcoplasmic reticulum Ca
2+
-ATPases) in the membrane and 102 
calsequestrin in the lumen (Boncompagni et al. 2012). 103 
We have previously shown hepatic insulin sensitivity but muscular insulin resistance in Chga-KO mice 104 
(Gayen et al. 2009). Here we show impaired muscle function, muscle fiber degeneration and decreased insulin 105 
signaling coupled with attenuated glucose uptake and metabolism in Chga-KO skeletal muscle. In addition, at 106 
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the ultrastructural level, we found the presence of TAs in gastrocnemius muscle of Chga-KO mice.  Treatment of 107 
Chga-KO mice with CgA for 15 days restored muscle performance, which establishes a novel role of CgA in 108 
regulation of skeletal muscle function.  109 
110 
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Materials and Methods 111 
 112 
Animals 113 
Adult (5-6 months old) male Chga-KO mice on a mixed genetic background (50% 129svJ; 50% 114 
C57BL/6J) and wild-type C57BL/6J mice were studied. Mice were kept on a 12 hr dark/light cycle, and fed ad 115 
libitum with a normal chow diet (NCD: 14% calories from fat; LabDiet 5P00). The Institutional Animal Care and 116 
Use Committee of the University of California San Diego approved all procedures.  117 
 118 
Immunoblotting 119 
 Tissues were homogenized in a lysis buffer containing phosphatase and protease inhibitors. 120 
Homogenates were subjected to 10% SDS-PAGE and immunoblotted. The following primary antibodies were 121 
obtained from Cell Signaling Technology (Boston, MA): AKT and pS473-AKT (rabbit polyclonal at 1:1000 122 
dilution), AMPK and pT172-AMPKa (rabbit polyclonal at 1:1000 dilution), P38 and pT180/Y182-P38 (rabbit 123 
polyclonal at 1:1000 dilution), TBC1D1, pT590-TBC1D1 and pS700-TBC1D1 (rabbit polyclonal at 1:500 124 
dilation). Anti-CgA (hCgA352-372) polyclonal antibody was raised in rabbit by a commercial vendor Sdix Inc. 125 
(Newark, DE) and used at a dilution of 1:1000. This antibody detected full-length CgA (75 kDa), proteoglycan 126 
form of CgA (90 kDa), and proteolytically processed CgA (49 kDa and 30 kDa). In addition, we also used anti-127 
CgA mouse monoclonal antibody 5A8 (epitope hCgAR47-L57) (Ratti, et al. 2000) at a dilution of 1:1000 that cross-128 
reacts with murine CgA (Colombo, et al. 2002). 129 
 130 
Real-time RT-PCR assay for measurement of target mRNAs 131 
 Total cellular RNA from GAS was isolated with TriPure Isolation Reagent (Invitrogen) and purified and 132 
DNase I treated with RNAeasy Mini Kit (Qiagen Inc. Valencia, CA). Either a Thermoscript kit (Invitrogen) or a 133 
qScript CDNA synthesis kit (Quantabio, Beverly, MA) was used for reverse transcription from total RNA. The RT 134 
products were amplified either with an RT2 Real-Time SYBR Green Kit (AuperArray, Fredrick, MD) or 135 
PERFECTA SYBR FASTMIX L-ROX 1250 (Quantabio, Beverly, MA). PCR reactions were run either on a 136 
MxP3000 Real-Time PCR system (Stratagene, La Jolla, CA) or an Applied Biosystems 7500 Fast Real-Time 137 
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PCR system (Foster City, CA). All PCRs were normalized to Gapdh, and relative expression levels were 138 
determined by the ∆∆Ct method. Primer sequences are provided in Table 1. 139 
 140 
2-deoxy-glucose (2DG) uptake and glucose metabolism.  141 
  In vivo glucose uptake and production of glucose-6-phosphate (G6P) was carried out essentially as 142 
described by Crosson et al. (Crosson, et al. 2003) but using double isotopes 
3
H-glucose and 
14
C-2-143 
deoxyglucose (2DG). To evaluate glucose uptake in GAS and formation of G6P in vivo, we injected a cocktail of 144 
3
H-glucose and 
14
C-2DG in 25% glucose solutions into sedentary WT and Chga-KO mice and looked at the 145 
uptake and metabolism after 90 min of injection. Since some glucose is trapped in extracellular and interstitial 146 
space, which may give an overestimation of uptake, we estimated the contribution of extracellular space to the 147 
uptake in each tissue by
 14
C-mannitol incorporation. Blood glucose was measured at 0 and 90 minutes after 148 
glucose injection. Mice were then sacrificed and tissues were dissected and frozen rapidly in liquid nitrogen. We 149 
determined 
3
H-glucose and 
14
C-2DG specific activities in blood samples. Tissue homogenates were 150 
deproteinized and neutralized, then the radioactivity in the supernatants was counted before and after passing 151 
through an anion exchange resin to remove 2-DG-6-phosphate (2DG6P) and G6P. The difference in 152 
radioactivity before and after resin treatment represents the amount of 2DG6P and G6P formed. We counted 153 
both 
3
H and 
14
C. We expect that 
14
C will represent 2DG uptake and 
3
H counts will represent glucose uptake as 154 
well as the extent of further metabolism (glycolysis and oxidation) and glycogen formation. Glucose metabolism 155 
was determined by the difference of 2DG6P and G6P. For treadmill endurance exercises, mice were run at a 156 
speed of 22 meter/min for 20 min per day for 15 days followed by immediate injection with 
3
H-glucose and 
14
C-157 
2DG in 25% glucose solutions for determination of 2DG uptake and metabolism 90 minutes after glucose 158 
injection. 159 
 160 
Palmitate uptake and metabolism 161 
To determine uptake of palmitic acid in GAS in vivo and formation of acid soluble metabolite (ASM), we 162 
injected 100 µl solution of U-
14
C-palmitic acid-BSA complex (molar ratio 2.5:1), containing 1 µCi and 250 µM 163 
palmitate, into sedentary WT and Chga-KO mice, and looked at the uptake and metabolism after 90 min of 164 
injection. For treadmill endurance exercise, mice were run at a speed of 22 meter/min for 20 min per day for 15 165 
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days followed by immediate injection of 100 µl solution of U-
14
C-palmitic acid-BSA complex. After 90 minutes, 166 
mice were sacrificed, blood was saved and tissues were put into a mixture of chloroform:methanol:water 167 
(1:2:0.8 vol/vol). Tissues were homogenized and centrifuged (10,000x g for 10 min). The pellets were used for 168 
protein assay after dissolving in 2N NaOH at 60˚C for 1 hour. To the supernatants, 0.25 ml chloroform and 0.5 169 
ml 1M NaCl in 1M HCl were added and the mixtures were vortexed vigorously and centrifuged (10000x g, 10 170 
min) to separate two clear layers. The lower chloroform layers containing all lipids were collected in scintillation 171 
vials, dried overnight and counted. This radioactivity represents the amount of fatty acids taken up by the tissue. 172 
Fatty acid concentration and radioactivity in the saved serum were determined to calculate specific activity of the 173 
radioactive fatty acid in serum. Oxidation of radioactive fatty acids is represented by the radioactivity in CO2 174 
formed and by the radioactivity in the acid-soluble materials (ASM) in the acidified supernatants. We only 175 
measured ASM for this work (did not measure 
14
CO2 formation). The upper acidic aqueous layers were 176 
neutralized and counted. 177 
 178 
Endurance tests  179 
WT and Chga-KO mice were exercised on an Omnipacer Treadmill LC4 (Omnitech Electronics, Inc., 180 
Columbus, OH) on a 10° incline while breathing room air. Subjecting mice to an incremental speed running test 181 
determined the maximal running capacity. Thus, mice were initially exercised at a speed of 24 m/min with 182 
increments of 2 m/min every 30 sec until exhaustion. To determine endurance capacity, mice were run on a 183 
treadmill at 20 m/min (60% of the average maximal speed of Chga-KO mice) at 10° inclination until exhaustion, 184 
which was defined as consistent refusal to run despite contact with the electrical grid at the rear of the treadmill. 185 
To find out the role of CgA in endurance exercise, Chga-KO mice were supplemented with recombinant CgA 186 
(0.05 µg/g BW, IP daily for 15 days) and tested their abilities in endurance exercise. Full-length human CgA1-187 
439 was prepared by recombinant DNA technology in Angelo Corti’s laboratory as described previously (Crippa, 188 
et al. 2013).  189 
 190 
Light and Transmission Electron Microscopy (TEM) 191 
Mice were deeply anesthetized and the gastrocnemius (GAS) muscles were perfusion fixed through the 192 
left ventricle. Mice were flushed with a pre-warmed (37°C) calcium and magnesium free buffer, which is 193 
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composed of DPBS (Life Technologies Inc. Carlsbad, CA), 10 mM HEPES, 0.2 mM EGTA, 0.2% bovine serum 194 
albumin, 5 mM glucose and 10 mM KCl for 3 min followed by perfusion with freshly prepared pre-warmed 195 
(37°C) fixative containing 2.5% glutaraldehyde, 2% paraformaldehyde in 0.15 M cacodylate buffer for 3 min 196 
using a peristaltic pump (5 ml/min; Langer Instruments Corp, Boonton, NJ). GAS muscles were dissected out 197 
and put in the same fixative overnight (2 hrs at room temperature and 12 hrs at 4°C), and postﬁxed in 1% OsO4 198 
in 0.1 M cacodylate buffer for 1 hour on ice. The tissues were stained en bloc with 2-3% uranyl acetate for 1 199 
hour on ice. The tissues were dehydrated in graded series of ethanol (20-100%) on ice followed by one wash 200 
with 100% ethanol and two washes with acetone (15 min each) and embedded with Durcupan. Longitudinal and 201 
transverse sections were cut at 50 to 60 nm on a Leica UCT ultramicrotome, and picked up on Formvar and 202 
carbon-coated copper grids. Sections were stained with 2% uranyl acetate for 5 minutes and Sato's lead stain 203 
for 1 minute. Grids were viewed using a JEOL 1200EX II (JEOL, Peabody, MA) TEM and photographed using a 204 
Gatan digital camera (Gatan, Pleasanton, CA). Micrographs were randomly taken from 3 GAS each from WT 205 
and Chga-KO mice, which were fixed and processed in two different days. 206 
 207 
Morphometric analysis 208 
Samples were blinded and 2 people did measurements randomly from different cells as described 209 
previously (Pasqua, et al. 2016). The free-hand tool in NIH ImageJ 1.49 software was used to manually trace 210 
around the cristae membrane, mitochondrial outer membrane area and cytoplasm area for determination of the 211 
mitochondrial and cristae volume density. The sum of the area of the total complement of cristae represented 212 
the cristae membrane surface area. To normalize the measurement, this area was divided by the outer 213 
membrane area per mitochondrion. The sum of the area of the mitochondria was divided by the area of the 214 
cytoplasm and multiplied by 100 to determine the mitochondrial volume density (%). For determination of the 215 
cristae volume density (%), the sum of the area of the cristae was divided by the outer area of the mitochondria 216 
and multiplied by 100, as described previously (Pasqua et al. 2016).  217 
 218 
Data presentation and statistical analysis 219 
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Data are expressed as mean ± SEM. Statistics were performed with GraphPad Prism 7 software 220 
(GraphPad software, Inc, La Jolla, CA). Data were analyzed with one-way ANOVA or 2-way ANOVA followed by 221 
multiple comparison tests where appropriate. Additionally, we performed unpaired Student’s t tests with Welch’s 222 
correction when appropriate. Statistical significance was defined as p<0.05. 223 
224 
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Results 225 
 226 
Loss of CgA impairs muscle performance. Although Chga-KO mice are 13% heavier than WT mice (Fig. 1a), 227 
the GAS muscle showed a 10% decrease in weight compared to WT mice (Fig. 1b).  Chga-KO mice showed a 228 
37% decrease in maximum running speed compared to WT mice (Fig. 1c) and also showed 48% decrease in 229 
endurance as measured by time to exhaustion (Fig. 1d). We then tested whether supplementation of CgA to 230 
Chga-KO mice would restore muscle function. We found that CgA supplementation restored both maximal 231 
capacity (Fig. 1e) and endurance performance (Fig. 1f) in Chga-KO mice, indicating an important role for CgA in 232 
skeletal muscle function. With the profound effect on exercise performance and muscle mass, we wondered 233 
whether CgA is expressed in GAS muscle. Western blot analyses with a CgA antiserum (hCgA352-372) confirmed 234 
CgA expression in GAS muscle (Fig. 1d). As positive controls, we used adrenal and pituitary glands, which 235 
showed major bands at 75 and 100 kDa, respectively.  Like the pituitary gland, GAS muscle showed a CgA 236 
proteoglycan band at 100 kDa. In addition, adrenal and pituitary glands showed a proteolytically processed band 237 
at 49 kDa but GAS muscle showed a 30 kDa fragment (Fig. 1g). Western blot analyses with anti-CgA mouse 238 
monoclonal antibody 5A8 (epitope hCgA47-57) (Ratti et al. 2000) capable of cross-reacting with murine CgA 239 
(Colombo et al. 2002) confirmed CgA expression in GAS muscle (Fig. 1h). Both CgA protein (Fig. 1h) and Chga 240 
mRNA (Fig. 1i) were undetectable in Chga-KO mice. We have also detected Chga mRNA in GAS muscle (Fig. 241 
1j). Amongst the tissues tested (GAS muscle, adrenal gland, pituitary gland, hypothalamus, and pancreatic 242 
islets), Chga expression appears to be lowest in GAS muscle (Fig. 1h-j). We also looked at the expression of 243 
other members of the Chromogranin/Secretogranin protein family (Chgb and Scg2), which revealed that multiple 244 
granins were detected, with Scg2 being the most highly expressed granin (Fig. 1i-n).   245 
 246 
Insulin-induced signaling. Previously we have shown muscle insulin resistance in Chga-KO mice (Gayen et 247 
al. 2009). Hence, we tested whether insulin signaling was impaired in GAS from Chga-KO mice. Insulin caused 248 
2.2- and 1.7-fold increments in AKT (Ser473) phosphorylation in WT mice and Chga-KO mice, respectively (Fig. 249 
2a&b); indicating impaired PI-3Kinase signaling in GAS muscle.  Insulin also activates the stress-activated 250 
p38MAPK (Somwar, et al. 2000), so we evaluated insulin-induced activation of p38MAPK. Insulin-induced 251 
phosphorylation of p38K was also significantly higher in WT mice than Chga-KO mice (2.0 versus 1.5-fold, 252 
Page 11 of 43
respectively), indicating a similar impairment in MAPK signaling pathway (Fig. 2a&d).  The TBC1D1 protein 253 
plays an important role in insulin and exercise-regulated Glut4 translocation (Sakamoto and Holman 2008; 254 
Middelbeek, et al. 2013) and AKT phosphorylates TBC1D1 at Thr590 in skeletal muscle (Vichaiwong, et al. 255 
2010).  Consistent with the AKT data, insulin increased phosphorylation of TBC1D1 at Thr590 2.6-fold in WT 256 
mice but not in Chga-KO mice, indicating a defect downstream of AKT in insulin signaling in Chga-KO mice (Fig. 257 
2a&c). 258 
 259 
Exercise-induced signaling. Exercise activates both AMPK (AMP-activated protein kinase), which is sensitive 260 
to the AMP/ATP ratio, and AKT in skeletal muscle (Sakamoto, et al. 2003) (Richter and Ruderman 2009). Both 261 
activated AKT and AMPK phosphorylate TBC1D1 but at distinct residues (Thr590 and Ser700, respectively) 262 
(Vichaiwong et al. 2010). Therefore, we assessed whether the impaired muscle function during exercise in 263 
Chga-KO mice is associated with impaired AKT or AMPK activation and phosphorylation of TBC1D1. While 264 
exercise caused 1.6-fold increase in phosphorylation of AKT at Ser473, it had no effect on AKT phosphorylation 265 
in Chga-KO mice (Fig. 3a&b). In contrast, exercise stimulated phosphorylation of AMPKα at Thr172 site was 266 
unchanged (1.5-fold in both WT and Chga-KO) (Fig. 3a&c). Although exercise stimulated phosphorylation of 267 
TBC1D1 at Thr590 1.4-fold (AKT site) and at Ser700 1.5-fold (AMPK site) in WT muscle, it had no effect on 268 
TBC1D1 phosphorylation in muscle from Chga-KO mice. These findings indicate that both AKT and AMPK-269 
mediated phosphorylation of TBC1D1 is compromised in Chga-KO mice. Exercise also activates p38MAPK in 270 
humans (Aronson, et al. 1997; Osman, et al. 2000) and rats (Goodyear, et al. 1996). Here, we found complete 271 
abolition of exercise-induced phosphorylation of p38MAPK in Chga-KO-GAS (Fig. 3a&f), suggesting that the 272 
adaptation mechanism to exercise–induced stress and damage has been compromised in Chga-KO-GAS.  273 
 274 
Glucose and fatty acid uptake and metabolism in response to exercise. In skeletal muscle, insulin and 275 
exercise are the most physiologically relevant stimulators of glucose transport via the translocation of Glut4 from 276 
intracellular depots to the sarcolemma and transverse tubules (Lauritzen, et al. 2010).  Activated AKT and 277 
AMPK phosphorylate TBC1D1 and activate its GTPase activity allowing Glut4 vesicle translocation. Although 278 
blood glucose levels were comparable between WT and Chga-KO mice (Fig. 4a), the expression of Glut4 was 279 
significantly reduced in Chga-KO GAS muscle (Fig. 4c). Endurance exercise stimulated both uptake of 2DG (by 280 
Page 12 of 43
1.8-fold) and utilization of G6P (by 1.6-fold) in WT mice, but both glucose uptake and utilization of G6P were 281 
decreased in the sedentary Chga-KO mice and did not change significantly with exercise (Fig. 4b&d). 282 
Decreased G6P content indicates increased glucose utilization. Chga-KO mice displayed decreased plasma 283 
triglycerides (Fig. 4e) and dramatically reduced expression of the fatty acid transporter Cd36 (Fig. 4g). Glucose 284 
and fatty acids are the main substrates that provide metabolic energy for the contractile activity of muscle. 285 
Although glucose uptake and metabolism were increased in WT muscle after endurance exercise, fatty acid 286 
uptake and metabolism were decreased (Fig. 4f) consistent with a switch from lipid oxidation to glucose 287 
utilization in GAS muscle. Similar to the findings for glucose utilization, sedentary Chga-KO mice showed 288 
decreased fatty acid uptake and oxidation, endurance exercise caused a further drop in fatty acid uptake and 289 
metabolism (Fig. 4h). Taken together these findings indicate that GAS muscle in Chga-KO mice shows impaired 290 
utilization of both glucose and fatty acids as an energy source.  291 
 292 
Expression of genes involved in regeneration and inflammation:  We assessed a panel of muscle 293 
progenitor and satellite cell markers in GAS muscle from WT and Chga-KO mice. In sedentary mice, we found 294 
increased expression of progenitor cell markers MyoD (4-fold) and Pax3 (3.4-fold) in Chga-KO mice compared 295 
to WT mice (Fig. 5a) but no change in satellite marker Myf5 (Relaix, et al. 2006; Young and Wagers 2010; 296 
Filareto, et al. 2015). Chga-KO mice also showed increased expression of pro-inflammatory genes Tnfα (1.8-297 
fold), Ifnγ (3.8-fold), and Il6 (7.3-fold) as well as expression of anti-inflammatory gene Il10 (by 5.6-fold) as 298 
compared to WT mice (Fig. 5b). It is possible that while the increased expression of MyoD1 and Pax3 may drive 299 
proliferation and differentiation of progenitor cells (Relaix et al. 2006; Young and Wagers 2010; Filareto et al. 300 
2015), increased expression of Ifnγ may inhibit myogenin activity and prevent differentiation (Londhe and Davie 301 
2011).  302 
 303 
Ultrastructural analysis of GAS muscle in sedentary mice  304 
 Hematoxylin/eosin staining of transverse sections of GAS muscle revealed morphological alterations in 305 
Chga-KO mice compared to WT (Fig. 6a&b). In particular, the sections from Chga-KO mice showed increased 306 
intermyofibrillar fibrosis as shown by increased expression of collagen type 1 alpha 1 (Col1a1), collagen type III 307 
alpha 1 (Col3a1), lysyl oxidase (Lox), fibronectin 1 (Fn1), and smooth muscle alpha-actin (Acta2) (Fig. 6 c-h) 308 
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and the demonstration of collagen fibers at the ultrastructural level (Fig. 6i-k). In addition, histological sections 309 
show central nucleation, smaller rounded fibers and unusual irregular clusters of dotted structures in the 310 
myofibrillar region suggesting tubular aggregation (Fig. 6a&b). These alterations prompted us to examine those 311 
structures at the ultrastructural level. 312 
In WT mice, we observed a mitochondrion in the intermyofibrillar (IMF) region on either side of the Z-313 
disc (perpendicular to the Z-disc) in longitudinal sections (Fig. 7a&b). In addition, we found triads consisting of 314 
T-tubules (TT) flanked by smooth sarcoplasmic reticulum (SSR) adjacent to the mitochondria (Fig. 7b&c). In 315 
contrast, these IMF structures were disrupted in Chga-KO-GAS with fewer or absent mitochondria, and smaller 316 
triad structures (Fig. 7d,e&f). In place of these IMF mitochondria, glycogen granules were detected either on one 317 
or both sides of the Z-disc in sedentary Chga-KO-GAS. Morphometric analysis of structures in Chga-KO-GAS 318 
indicated decreased mitochondrial density and area (Fig. 7g&h). However, there were no significant changes in 319 
cristae density or area for the remaining mitochondria (Fig. 7i&j). Defective mitochondrial function in sedentary 320 
Chga-KO-GAS was observed by the decreased cytochrome C oxidase (CCO) activity compared to WT mice 321 
(Fig. 7k). Subsarcolemmal mitochondria (SSM) displayed prominent cristae in WT mice (Fig. 8a&b), but SSM 322 
mitochondria were smaller in size and with fewer cristae in Chga-KO mice (Fig. 8c&d). In addition, we observed 323 
mitophagy, and inclusion body and glycogen granules in the subsarcolemmal region in Chga-KO mice (Fig. 324 
8c&d). 325 
 We also examined the ultrastructure of exercised muscle. IMF mitochondria in exercised WT mice were 326 
enlarged but maintained their localization perpendicular to the Z-disc (Fig. 9a), whereas exercised Chga-KO-327 
muscle showed decreased numbers of mitochondria and increased observation of tubular aggregates (TA) (Fig. 328 
9b). Higher magnification revealed dilated cristae in both the SSM and IMF mitochondria of WT mice, (Fig. 329 
9c&e) but mitochondria in exercised Chga-KO mice displayed smaller round or ovoid cristae (Fig. 9d&f). 330 
In WT mice, tubular aggregates (TAs) were not detected in the subsarcolemmal as well as myofibrillar 331 
regions in transverse sections (Fig. 10a&b).  As compared to longitudinal sections, mitochondria in the 332 
myofibrillar regions appear elongated and connected in transverse sections (Fig. 10a&b). In contrast to WT 333 
mice, TAs were observed in sedentary Chga-KO mice in both transverse (Fig. 10c&d) and longitudinal (Fig. 334 
10e&f) sections. In addition, TAs are detected both in the subsarcolemmal (Fig. 10c&e) and myofibrillar (Fig. 335 
10d&f) regions. TAs are characterized as densely packed aggregates of vesicular or tubular membranes of 336 
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variable form and size. In transverse sections, the TAs appear as a honeycomb-like structure displaying a para-337 
crystalline order (Fig. 10c&d, 11a). In longitudinal sections, the TAs run parallel to the sarcomeres (Fig. 10e&f, 338 
11b). The TAs were either single-walled (Fig. 11c&d) or double-walled empty tubules (Fig. 11 e&f) and contain 339 
mitophagy structure (Fig. 11c). Glycogen granules were occasionally found between the double-walled tubules 340 
(Fig. 11e). Tubules in large aggregates show sub-clusters with different tubule orientation relative to the 341 
sarcomere (Fig. 11a) either longitudinal, oblique or perpendicular within a single section (Fig. 11 a,b,&f).  342 
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Discussion 344 
 345 
The secretory proprotein CgA is widely expressed in endocrine and neuroendocrine tissues as well as in the 346 
central nervous system, and is co-released with the resident hormones (Winkler and Fischer-Colbrie 1992; 347 
Montero-Hadjadje et al. 2008; Bartolomucci et al. 2011). Here, we detected CgA expression in GAS muscle and 348 
found that its absence, in Chga-KO mice, caused impaired muscle function. Based on the very low mRNA level 349 
yet strong protein expression it is possible that the source of processed CgA is from the axon terminals that 350 
innervate the muscle rather than the muscle cell itself. It has been reported that mRNA is transported from the 351 
cell body to the axon terminal where it is translated into protein and released exocytotically into the innervating 352 
tissue (Kar, et al. 2013; Jung, et al. 2014; Gervasi, et al. 2016). Hence the effects of CgA may well be paracrine 353 
in origin rather than autocrine. Secretogranin II, another member of the chromogranin/secretogranin protein 354 
family, has also been detected in hind limb muscle and cultured myotubes (Egger, et al. 2007). Supplementation 355 
with CgA in Chga-KO mice restored exercise ability. Together this data suggest a novel role for endogenous 356 
CgA in skeletal muscle function. It should be pointed out that the full-length CgA protein has recently been 357 
implicated in the regulation of myocardial contractility and angiogenesis (Crippa et al. 2013; Pasqua, et al. 358 
2013). However, it remains to be established whether CgA activity in muscle function requires local processing 359 
to smaller bioactive fragments or not. 360 
The signature defects that characterize the muscle phenotype in Chga-KO mice are (i) lack of exercise-361 
induced stimulation of pAKT, pTBC1D1 and phospho-p38MAPK signaling, (ii) loss of GAS muscle mass, (iii) 362 
extensive formation of TA, (iv) disorganized cristae architecture in mitochondria, and (v) increased expression of 363 
Tnfα and Ifnɣ.  We believe that the impaired maximum running speed and endurance in the treadmill exercise in 364 
Chga-KO mice are due to decreased in glucose uptake and glycolysis, and defects in glucose oxidation caused 365 
by defective mitochondria. In addition, the lack of adaptation to endurance exercise likely results from the 366 
impaired activation of stress responses, possibly resulting in deficiency in proliferation and differentiation of 367 
myogenic cells. It should be pointed out that Chga-KO mice are unique showing increased insulin sensitivity in 368 
the face of persistent hypertension (Mahapatra et al. 2005; Gayen et al. 2009; Biswas, et al. 2012; 369 
Bandyopadhyay, et al. 2015).   370 
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Decreased insulin-induced AKT phosphorylation at Ser473 and comparable phosphorylation of TBC1D1 371 
at Thr590 confirm the muscle resistance phenotype that we have reported earlier (Gayen et al. 2009). Fibrosis is 372 
increasingly appreciated as a major contributor to metabolic dysregulation in obese humans and type 2 373 
diabetics, and increased expression of collagen was observed in Chga-KO muscle, which may contribute to the 374 
insulin-resistant state (Sun, et al. 2013). Although AMPK signaling in response to exercise was normal in Chga-375 
KO-GAS, it was ineffective at activating TBC1D1 signaling, which correlated with the reduced the ability of 376 
exercise to stimulate glucose uptake.  Activation of p38 MAPK during muscle contraction can stimulate 377 
expression of Pgc1α, Atf2 and Mef2 and mediate mitochondrial adaptation (Akimoto, et al. 2005) and the 378 
p38MAPKɣ-PGC1α pathway is central to the adaptive response to tissue damage in muscle (Pogozelski, et al. 379 
2009). So the lack of stimulation of p38MAPK by either insulin or exercise likely prevented the post-exercise 380 
adaptation to tissue damage in the Chga-KO mice.  381 
The gene expression pattern in Chga-KO-GAS suggested that mice were attempting to compensate for 382 
the impaired muscle function due to the loss of CgA by increasing the proliferation and differentiation of Myod 383 
and Pax3 positive progenitor cells (Relaix et al. 2006; Young and Wagers 2010; Filareto et al. 2015). But the 384 
damaged muscle also triggers an immune response and the increased expression of Ifnɣ could inhibit 385 
myogenin, via the major histocompatibility complex class II transactivator CIITA, and MyoD activities and 386 
prevent differentiation (Londhe and Davie 2011; Villalta, et al. 2011). Furthermore, the increased expression of 387 
IL-6 may have negative effects on glucose uptake in muscle (Kim, et al. 2004). 388 
Mitochondria are essential to muscle function as they allow the efficient oxidation of glucose for the 389 
generation of ATP for contraction. Although the cristae volume density and cristae area are comparable in 390 
mitochondria between WT and Chga-KO mice, the decrease in mitochondrial number, volume density and area 391 
point to decreased mitochondrial function. Indeed cytochrome c oxidase (CCO) activity is decreased in Chga-392 
KO muscle. The CCO enzyme complex is found on the inner mitochondrial membrane and serves as the final 393 
electron acceptor in mitochondrial electron transport, and has been reported to increase after endurance 394 
exercise (Samelman, et al. 2000). Thus, decreased CCO activity in Chga-KO GAS muscle coupled with 395 
decreased endurance performance is consistent with reduced mitochondrial function (Samelman et al. 2000).  396 
Although TAs were first described by Engel in 1964 as granular “crystal-like” inclusions in skeletal 397 
muscle (Engel 1964), the mechanisms underlying the formation of TAs and their functional significance for 398 
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muscle function has remained elusive (Schubert et al. 2007; Schiaffino 2012). Our findings indicate an inverse 399 
association between TAs and exercise performance.  TA structures can be generated in vitro by hypoxia in 400 
extensor digitorum longus (EDL) muscle or by potassium cyanide (Schiaffino et al. 1977).  The detection of 401 
ubiquitin and hsp72 in these structures (Martin, et al. 1991; Muchowski and Wacker 2005) (Luan, et al. 2009), 402 
has led to the suggestion that the formation of TAs in skeletal muscle is comparable to formation of protein 403 
aggregates in neurodegenerative diseases but in these diseases protein aggregation occurs due to misfolding of 404 
proteins (Balch, et al. 2008; Douglas and Dillin 2010). In case of TAs, it was suggested that membrane-bound 405 
misfolded proteins could potentially induce aggregation of SR membranes to which they are bound by cross-406 
linking but experimental evidence is lacking (Schiaffino 2012). One of the major functions of CgA is to sort 407 
proteins to the regulated secretory pathway (Chanat, et al. 1991; Taupenot, et al. 2002; Bartolomucci et al. 408 
2011). Although the role of CgA in sorting or folding of membrane proteins is yet to be established, one could 409 
speculate such a role based on the observed pH-dependent association of CgA with secretory vesicle 410 
membranes (Yoo 1993). Therefore, lack of CgA could cause misfolding of membrane proteins allowing 411 
formation of TAs.  412 
 In conclusion, CgA deficiency causes a myopathic signature in skeletal muscle displaying extensive 413 
formation of TA signifying SR reorganization into multiple longitudinally oriented tubules with SERCA in the 414 
membrane and calsequestrin in the lumen. This myopathy is also characterized by muscle energy deficiency 415 
and the inability to regenerate after exercise-induced tissue damage. The net result is impaired performance in 416 
treadmill exercise. 417 
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Legends to the Figures. 
 
Figure 1. Impaired endurance capacity in Chga-KO mice. (a) Increased body weight in 
Chga-KO mice. (b) GAS muscle weight is decreased in Chga-KO mice. (c) The VO2 maximal 
speed in an incremental treadmill running test in WT and Chga-KO mice. (d) Endurance 
exercise capacity was evaluated by the time to reach exhaustion when mice were run at 60% 
of the average VO2 maximal speed. Supplementation of Chga-KO mice with CgA for 15 
days restored endurance capacity. (e) Maximal speed. (f) Endurance exercise capacity. 
Expressions of CgA/Chga in GAS muscle. (g&h) Western blot showing expression of CgA 
GAS muscle in WT mice and no expression in Chga-KO (KO) mice. (i) Expression of Chga in 
WT and Chga-KO mice. Expressions of Chga, Chgb, and Scg2 genes in GAS muscle (j), 
adrenal gland (k), pituitary gland (l), hypothalamus (m), and pancreatic islets (n). 
  
Figure 2. Assessment of insulin-induced signaling by Western blot in GAS muscle. 
Mice were treated with saline or insulin (0.4 mU/g BW) for 10 minutes before tissue 
harvesting. (a) Western blots showing expression of phospho-AKT at Ser473, total AKT, 
phospho-TBC1D1 at Thr590, total PBC1D1, phospho-P38 at Thr180/Tyr182, and total P38 in 
WT and Chga-KO mice. Densitometric values showing pS473-AKT/total AKT (b), pT590-
TBC1D1/total TBC1D1 (c), and pT180/Y182-P38/total P38 in WT and Chga-KO mice after 
endurance exercise. Note compromised insulin-induced signaling in Chga-KO mice. 
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Figure 3. Evaluation of exercise-induced signaling by Western blot in WT and Chga-KO 
GAS muscle. Mice were treated with saline or insulin (0.4 mU/g BW) for 10 minutes before 
tissue harvesting. Western blots showing expression of phospho-AKT at Ser473, total AKT, 
AMPKα at Thr172, total AMPK, phospho-TBC1D1 at Thr590, phospho-TBC1D1 at Ser700, 
total PBC1D1, phospho-P38 at Thr180/Tyr182, and total P38 in WT and KO mice. 
Densitometric values showing pS473-AKT/AKT (b), pT172-AMPK/AMPK (c), pT590-
TBC1D1/TBC1D1 (d), pS700-TBC1D1/TBC1D1 (e), and pT180/Y182-P38/P38 (f). Note 
compromised exercise-induced signaling in Chga-KO mice. 
 
Figure 4. Substrate uptake and metabolism in sedentary and exercised WT and Chga-
KO GAS muscle. (a) Blood glucose. (b) 2-deoxy glucose (2DG) uptake. (c) Glut4 mRNA 
level. (d) Plasma triglyceride (TG). (e) Utilization of glucose-6-phosphate (G6P). Note low 
G6P content is an indication of increased G6P utilization. (f) Fatty acid (palmitic acid) uptake. 
(g) Expression of Cd36 gene. (h) Fatty acid oxidation (as evaluated by the amount of acid 
soluble metabolites). Note low values indicate decreased fatty acid oxidation. 
 
Figure 5. Gene expression in sedentary WT and Chga-KO mice. (a) Relative mRNA 
levels of myogenin (Myog), myogenic differentiation antigen (MyoD), nestin (Nes), myogenic 
factor 5 (Myf5), paired box gene 3 (Pax3), paired box gene 7 (Pax7), and vascular endothelial 
growth factor (Vegf) genes. (b) Relative mRNA levels of F-box only protein 32(Fboxo32/ 
Atrogin1), ring finger protein 28 (Trim63/Murf1), tumor necrosis factor alpha (Tnfα), interferon, 
gamma (Ifnγ), interleukin 6 (Il6), interleukin 1 beta (I1βinterleukin 10 (Il10) genes. 
Statistical analyses were made by multiple t tests using Holm-Sidak’s correction method. 
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 Figure 6. Increased fibrosis in GAS muscle of sedentary mice. (a&b) Hematoxylin and 
eosin-stained transverse sections of GAS muscle in sedentary WT and Chga-KO mice. The 
arrows show dot-like irregular structures in the myofibrillar region. Expression of fibrotic 
genes: Collagen type I alpha 1 (Col1a1) (c&d), collagen type III alpha 1 (Col3a1) (c&e), Lysyl 
oxidase (Lox) (c&f), fibronectin 1 (Fn1) (c&g), and smooth muscle aortic alpha-actin (Acta2) 
(c&h). Transmission electron microscope (TEM) micrographs showing accumulation of 
collagen: Low magnification (2900x) photographs in WT and Chga-KO GAS muscle (i&j). 
High magnification (23,000x) photographs showing collagen in Chga-KO muscle (k). COL, 
collagen; GLY, glycogen; SSM, subsarcolemmal mitochondria; TT, T-tubule. 
 
Fig. 7. TEM micrographs in GAS muscle of sedentary mice. Intermyofibrillar (IMF) 
mitochondria at magnification 2500x (a), 15,000x (b), and 30,000x in WT mice. Note the triad 
comprising of T-tubule (shown by black arrow) flanked by smooth sarcoplasmic reticulum 
(shown by red arrow). IMF mitochondria at magnification 2500x (d), 15,000x (e), and 30,000x 
(f) in Chga-KO mice. Note glycogen (GLY) granules either in one or both sides of the Z-disc 
and smaller triad in Chga-KO mice. Morphometric analyses (15 mitochondria from 15 
sections per mouse for a total of 4 mice) of TEM micrographs from sedentary WT and 
Chga-KO mice. (g) Mitochondrial volume density (%). (h) Mitochondrial area (nm2). (i) 
Cristae volume density (%). (j) Cristae area (nm2). (k) Cytochrome C oxidase (CCO) activity 
in sedentary WT and Chga-KO mice. 
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Fig. 8. Subsarcolemmal mitochondria (SSM) in sedentary WT and Chga-KO GAS 
muscle. SSM and IMF mitochondria at magnification 2500x in WT mice. (b) SSM at 
magnification 30,000x in WT mice. Note cristae emerging from the inner mitochondrial 
membrane. (c) SSM and IMF mitochondria at magnification 2500x in Chga-KO mice. Note 
inclusion body in the subsarcolemmal region. (d) SSM at magnification 30,000x in Chga-KO 
mice. Note mitophagy (MPG), fewer cristae and glycogen granules (GLY). 
 
Fig. 9. Mitochondria and TA in exercised longitudinally sectioned WT and Chga-KO 
GAS muscle. (a) IMF mitochondria at 2500x in WT mice. (b) TA at 2500x in Chga-KO mice. 
(c) SSM at 30,000x with dilated cristae and long cristae in WT mice. (d) SSM at 30,000x with 
round, oval and smaller cristae in Chga-KO mice. (e) IMF mitochondria at 30,000x with 
dilated cristae and T-tubule in WT mice. (f) IMF mitochondria at 30,000x with dilated cristae 
and normal triad. Black arrow points to T-tubule and red arrow points to smooth sarcoplasmic 
reticulum. 
 
Fig. 10. Tubular aggregates (TAs) in sedentary Chga-KO GAS muscle. (a&b) Transverse 
sections showing SSM and IFM and the absence of TA in subsarcolemmal and myofibrillar 
regions. Note elongated IFM. TAs in transverse sections. TA in subsarcolemmal (c) and 
myofibrillar (d) regions. TAs in longitudinal sections.  TA in subsarcolemmal (e) and 
myofibrillar (f) regions. Arrow points to sarcolemma. 
 
Fig. 11. Tubular aggregates (TAs) in sedentary Chga-KO GAS muscle. (a) Transverse 
section showing a large aggregate where sub-clusters display different tubule orientation 
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relative to the sarcomere and mitochondria (MITO) in the outer border of TA. The inset shows 
a honeycomb-like TA. (b) Longitudinal section showing a TA, which runs parallel to the 
sarcomere. (c) Longitudinal section showing a TA with paracrystalline single-walled tubules of 
comparable area and a damaged mitochondrion (mitophagy). (d) Longitudinal section 
showing a TA, where paracrystalline tubules are of different areas. (e) Longitudinal section 
showing a TA with double-walled tubules and glycogen (GLY) granules in between two 
tubules. (f) Longitudinal section showing a TA where tubules are cut in the longitudinal, 
oblique or perpendicular to the sarcomere. Note triad and glycogen granules in the vicinity of 
TA. Black arrow points to T-tubule and red arrow points to smooth sarcoplasmic reticulum. 
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Table 1. Primer sequences for genes used in the real-time PCR analysis 
 
Description    Sequence 5’-3’ 
Acta2/a-Sma-FP   TCCCAGACATCAGGGAGTAA 
Acta2/a-Sma-RP   TCGGATACTTCAGCGTCAGGA 
Cd36-FP    ATGGGCTGTGATCGGAACTG 
Cd36-RP    GTCTTCCCAATAAGCATGTCTCC 
Chga-FP    CCAAGGTGATGAAGTGCGTC 
Chga-RP    GGTGTCGCAGGATAGAGAGGA 
Chgb-FP    AGCTCCAGTGGATAACAGGGA 
Chgb-RP    GATAGGGCATTTGAGAGGACTTC 
Col1a1-FP    GTGCTCCTGGTATTGCTGGT 
Col1a1-RP    GGCTCCTCGTTTTCCTTCTT 
Col3a1-FP    GGGTTTCCCTGGTCCTAAAG 
Col3a1-RP    CCTGGTTTCCCATTTTCTCC 
Fn1-FP    TTGAGGAACATGGCTTTAGGC 
Fn1-RP    CTGGGAACATGACCGATTTG 
Fbx032/Atrogin1-FP  CAGCTTCGTGAGCGACCTC 
Fbx032/Atrogin1-RP  GGCAGTCGAGAAGTCCAGTC 
Gapdh-FP    AGGTCGGTGTGAACGGATTTG 
Gapdh-RP    TGTAGACCATGTAGTTGAGGTCA 
Slc2a4/Glut4-FP   ACACTGGTCCTAGCTGTATTCT 
Slc2a4/Glut4-RP   CCAGCCACGTTGCATTGTA 
Ifng-FP    ATGAACGCTACACACTGCATC 
Ifng-RP    CCATCCTTTTGCCAGTTCCTC 
Il1b-FP    GCAACTGTTCCTGAACTCAACT 
Il1b-RP    ATCTTTTGGGGTCCGTCAACT 
Il6-FP     TAGTCCTTCCTACCCCAATTTCC 
Il6-RP     TTGGTCCTTAGCCACTCCTTC 
Il10-FP    GCTCTTACTGACTGGCATGAG 
Il10-RP    CGCAGCTCTAGGAGCATGTG 
Lox-FP    TCCGCAAAGAGTGAAGAACC 
Lox-RP    CATCAAGCAGGTCATAGTGG 
Myf5-FP    AAGGCTCCTGTATCCCCTCAC 
Myf5-RP    TGACCTTCTTCAGGCGTCTAC 
Nes-FP    CCCTGAAGTCGAGGAGCTG  
Nes-RP    CTGCTGCACCTCTAAGCGA 
Myod1-FP    CCACTCCGGGACATAGACTTG 
Myod1-RP    AAAAGCGCAGGTCTGGTGAG 
Myog-FP    GAGACATCCCCCTATTTCTACCA 
Myog-RP    GCTCAGTCCGCTCATAGCC 
Pax3-F    CCGGGGCAGAATTACCCAC 
Pax3-RP    GCCGTTGATAAATACTCCTCCG 
Pax7-FP    TCTCCAAGATTCTGTGCCGAT 
Pax7-RP    CGGGGTTCTCTCTCTTATACTCC 
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Scg2-FP    GGAGCTAAGGCGTACCGAC 
Scg2-RP    TGGACATTCTCCAATCTGAGGT 
Tnf-FP    CCCTCACACTCAGATCATCTTCT 
Tnf-RP    GCTACGACGTGGGCTACAG 
Trim63/Murf1-FP   GTGTGAGGTGCCTACTTGCTC 
Trim63/Murf1-RP   GCTCAGTCTTCTGTCCTTGGA 
Vegfa-FP    CTGCCGTCCGATTGAGACC 
Vegfa-RP    CCCCTCCTTGTACCACTGTC 
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